aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.285
+0.185 (5.97%)
Apr 21, 2025, 4:00 PM EDT - Market closed
aTyr Pharma Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for aTyr Pharma stock have an average target of 18.6, with a low estimate of 9.00 and a high estimate of 35. The average target predicts an increase of 466.21% from the current stock price of 3.29.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 14, 2025.
Analyst Ratings
The average analyst rating for aTyr Pharma stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Mar 14, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +387.06% | Feb 18, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +965.45% | Dec 3, 2024 |
Financial Forecast
Revenue This Year
1.53M
from 235.00K
Increased by 551.06%
Revenue Next Year
34.35M
from 1.53M
Increased by 2,144.84%
EPS This Year
-0.72
from -0.86
EPS Next Year
-0.53
from -0.72
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 12.6M | 123.9M | 240.6M |
| Avg | 1.5M | 34.3M | 129.5M |
| Low | n/a | n/a | 19.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5,261.7% | 7,998.0% | 600.4% |
| Avg | 551.1% | 2,144.8% | 277.0% |
| Low | - | - | -42.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.60 | 0.29 | 1.08 |
| Avg | -0.72 | -0.53 | 0.15 |
| Low | -0.90 | -1.23 | -0.81 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.